<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">urovest</journal-id><journal-title-group><journal-title xml:lang="ru">Вестник урологии</journal-title><trans-title-group xml:lang="en"><trans-title>Urology Herald</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2308-6424</issn><publisher><publisher-name>Rostov State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21886/2308-6424-2018-6-1-94-99</article-id><article-id custom-type="elpub" pub-id-type="custom">urovest-196</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОТЧЕТЫ О НАУЧНО-ОБРАЗОВАТЕЛЬНЫХ МЕРОПРИЯТИЯХ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>STATEMENTS OF RESEARCH AND EDUCATIONAL EVENTS</subject></subj-group></article-categories><title-group><article-title>ЕВРОПЕЙСКОЕ ОБЩЕСТВО ОНКОУРОЛОГИЧЕСКОЙ УРОЛОГИИ (ESOU): НОВОЕ ЗА 2017 ГОД</article-title><trans-title-group xml:lang="en"><trans-title>EUROPEAN SECTION OF ONCOLOGICAL UROLOGY (ESOU): NEW DATA IN 2017</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5183-5153</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рева</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Reva</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н, врач онколог, уролог, научный сотрудник отделения онкоурологии,</p><p> Санкт-Петербург</p></bio><bio xml:lang="en"><p>MD PhD, oncologist, urologist, scientific researcher, oncourological department,</p><p>Saint-Petersburg</p></bio><email xlink:type="simple">sgreva79@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «НМИЦ онкологии им. Н.Н. Петрова» МЗ РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.N. Petrov Research Institute of Oncology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>31</day><month>03</month><year>2018</year></pub-date><volume>6</volume><issue>1</issue><fpage>94</fpage><lpage>99</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Рева С.А., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Рева С.А.</copyright-holder><copyright-holder xml:lang="en">Reva S.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.urovest.ru/jour/article/view/196">https://www.urovest.ru/jour/article/view/196</self-uri><abstract><p>Прошедший год был насыщен информацией из новых исследований, многие из которых уже внедрены в стандарты. Безусловно, в коротком сообщении невозможно осветить все значимые работы года, однако на конгрессе ESOU были отражены все тенденции, актуальные на сегодняшний и перспективные на завтрашний день в диагностике и лечении основных онкоурологических заболеваний.</p></abstract><trans-abstract xml:lang="en"><p>Summary. The past year has been saturated with information from new research, many of which have already been introduced into the standards. Of course, in a short message it is impossible to cover all the significant works of the year, but at the ESOU congress summarized all the trends that are relevant for actual and promising for the future in the diagnosis and treatment of major oncological diseases.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>рак простаты</kwd><kwd>рак почки</kwd><kwd>рак мочевого пузыря</kwd><kwd>онкология</kwd><kwd>урология</kwd></kwd-group><kwd-group xml:lang="en"><kwd>prostate cancer</kwd><kwd>renal cancer</kwd><kwd>bladder cancer</kwd><kwd>oncology</kwd><kwd>urology</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
